Compare CORT & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | MASI |
|---|---|---|
| Founded | 1998 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 7.6B |
| IPO Year | N/A | 2007 |
| Metric | CORT | MASI |
|---|---|---|
| Price | $87.64 | $137.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $139.00 | ★ $188.80 |
| AVG Volume (30 Days) | 690.9K | ★ 771.5K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | $741,172,000.00 | ★ $2,182,000,000.00 |
| Revenue This Year | $23.79 | N/A |
| Revenue Next Year | $40.97 | $6.83 |
| P/E Ratio | $100.74 | ★ N/A |
| Revenue Growth | 17.92 | ★ 38.48 |
| 52 Week Low | $49.00 | $133.70 |
| 52 Week High | $117.33 | $194.88 |
| Indicator | CORT | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 67.59 | 40.69 |
| Support Level | $81.31 | $137.00 |
| Resistance Level | $87.19 | $142.63 |
| Average True Range (ATR) | 2.87 | 4.51 |
| MACD | 0.69 | -0.46 |
| Stochastic Oscillator | 88.95 | 13.54 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.